Annual Grant Award Dollars

Investigator Title Sponsor ID Dates Amount
Charles T Quinn, MD A Pilot Study of Imatinib in patients with Sickle Cell Disease and Recurrent Vaso-occlusive Pain Purdue University PU - Quinn,Charles 10/16/2019 - 10/15/2024 $83,071
Charles T Quinn, MD DISPLACE: Dissemination and Implementation of Stroke Prevention: Looking at the Care Environment University of Alabama-Birmingham (National Institutes of Health) 000524452-002 01/01/2019 - 06/30/2019 $3,609
Cristina Tarango, MD ATHN 11 American Thrombosis & Hemostatis Network ATHN - Tarango,Crist 09/01/2019 - 08/31/2020 $20,000
Cristina Tarango, MD Hemophilia and Thrombosis Center Hemophilia Foundation of Michigan Tarango, CHC,HFM 06/01/2020 - 05/31/2021 $154,596
Cristina Tarango, MD Community Counts: Public Health Surveillance for Bleeding Disorders Hemophilia Foundation of Michigan (Ctr for Disease Control and Prevention) U27DD001155 09/30/2019 - 09/29/2020 $27,250
Cristina Tarango, MD Region V East Comprehensive Care Network for Bleeding Disorders Hemophilia Foundation of Michigan (Maternal & Child Health Bureau) H30MC24047 06/01/2019 - 05/31/2020 $22,000
Eric Mullins, MD Mechanisms linking hemostatic factors and neuroinflammatory disease National Institutes of Health (NIH) R01NS107258 03/01/2020 - 02/28/2021 $412,354
Joseph S Palumbo, MD Hemostatic Factors Drive Prostate Cancer Pathogenesis National Institutes of Health (NIH) R01CA193678 04/01/2020 - 03/31/2021 $356,850
Joseph S Palumbo, MD Coagulation factors as modifiers of the colon cancer microenvironment National Institutes of Health (NIH) R01CA204058 04/01/2020 - 03/31/2021 $356,850
Lisa M Littner LISW-S Health for Hemophilia The Hemophilia Alliance Foundation Littner, HAF 04/01/2020 - 03/31/2021 $8,000
Lisa M Shook Sickle Treatment and Outcomes Research in the Midwest (STORM) Health Resources & Services Admin U1EMC27863 09/01/2019 - 08/31/2020 $536,250
Lisa M Shook Cincinnati Sickle Cell Project Ohio Department of Health 03130011SK1320 07/01/2019 - 06/30/2020 $125,957
Lori Luchtman-Jones, MD Prospective validation of a venous thrombosis risk assessment model in critically ill children from the CHAT Registry (CHAT 1901) Children's Hospital Los Angeles 1901 03/01/2020 - 02/28/2025 $8,033
Luke R Smart, MD Genetic modifiers of sickle cell anemia and hemoglobin F production in northwest Tanzania American Society of Hematology Smart, Luke:ASH 07/01/2019 - 06/30/2020 $70,000
Luke R Smart, MD Bedside Expedited Testing for Anemia (BETA) Thrasher Research Fund Smart, Luke, TRF 07/01/2019 - 06/30/2020 $8,335
Patrick McGann, MD-MS Maximizing Fetal Hemoglobin Responses to Hydroxyurea using Precision Medicine Doris Duke Charitable Foundation 2017090 09/01/2019 - 08/31/2020 $330,000
Patrick McGann, MD-MS Therapeutic Response Evaluation and Adherence Trial: A Prospective Study of Hydroxyurea for Children with Sickle Cell Anemia National Institutes of Health (NIH) K23HL128885 06/01/2019 - 05/31/2021 $187,649
Russell Ware, MD-PHD A cloud-based decision support platform for precision dosing in sickle cell disease Cleveland Clin Lerner Col of Med of CWRU (National Institutes of Health) 1232-Sub 08/01/2019 - 07/31/2020 $119,250
Russell Ware, MD-PHD Validation of Cross-Species Biomarkers of DNA Damage Litron Laboratories (National Institutes of Health) R44ES028163 09/01/2019 - 08/31/2020 $39,147
Russell Ware, MD-PHD Realizing Effectiveness Across Continents with Hydroxyurea (REACH): A Phase I/II Pilot Study of Hydroxyurea for Children with Sickle Cell Anemia National Institutes of Health (NIH) U01HL133883 08/01/2019 - 07/31/2020 $676,152
Theodosia A Kalfa, MDPHD The Role of Erythroblastic Islands in Anemia of Inflammation National Institutes of Health (NIH) R01HL152099 04/01/2020 - 03/31/2021 $634,684
Current Year Direct $4,180,037

Annual Industry Award Dollars

Investigator Industry Sponsor Amount
Adrienne Hammill, MD ArQule, Inc $106,503.00
Eric Mullins, MD Baxalta US, Inc. $266,315.00
Eric Mullins, MD Spark Therapeutics, Inc. $26,380.00
Punam Malik, MD FORMA Therapeutics, Inc. $218,261.00
Russell Ware, MD-PHD Celgene Cellular Therapeutics $100,000.00
Theodosia A Kalfa, MDPHD Agios Pharmaceuticals $86,316.00
Total Annual Industry Award Dollars $803,775.00